Javelin Head Neck 100: Should we combine immunotherapy with radiation therapy? Editorial

   

Authors:	Yu, Y.; Zakeri, K.; Lee, N.
Title:	Javelin Head Neck 100: Should we combine immunotherapy with radiation therapy?
Keywords:	overall survival; drug tolerability; review; cisplatin; disease free survival; chemotherapy; cd8+ t lymphocyte; cancer immunotherapy; progression free survival; maintenance therapy; cetuximab; distant metastasis; immunotherapy; immunoglobulin g; head and neck cancer; esophagus resection; radiation therapy; hazard ratio; locally advanced; oropharynx carcinoma; chemoradiotherapy; wart virus; programmed death 1 ligand 1; head and neck squamous cell carcinoma; randomized controlled trial (topic); phase 2 clinical trial (topic); phase 3 clinical trial (topic); nivolumab; human; pembrolizumab; durvalumab; atezolizumab; avelumab
Journal Title:	Oncotarget
Volume:	12
Issue:	21
ISSN:	1949-2553
Publisher:	Impact Journals
Date Published:	2021-10-12
Start Page:	2223
End Page:	2226
Language:	English
DOI:	10.18632/oncotarget.27987
PROVIDER:	scopus
PMCID:	PMC8522846
PUBMED:	34676054
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118781986&doi=10.18632%2fONCOTARGET.27987&partnerID=40&md5=356a6fa04b1d352c3980ae6ce3d6fbd5
Notes:	Review -- Export Date: 1 December 2021 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/190468